Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 181 AL 195

Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer's Disease

Strac DS, Konjevod M, Perkovic MN, Tudor L, Erjavec GN, Pivac N.

Curr Alzheimer Res. 2020;17(2):141-157. doi: 10.2174/1567205017666200317092310.

Association between ALDH2 Gene Polymorphism and Late-onset Alzheimer Disease: An Up-to-date Meta-analysis

Liu H, Ge W, Chen W, Kong X, Jian W, Wang A.

Curr Alzheimer Res. 2020;17(2):105-111. doi: 10.2174/1567205017666200317102337.

[Pharmacological prevention of cognitive decline and dementia]

Jessen F.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 May;63(5):506-511. doi: 10.1007/s00103-020-03120-z.

Molecular mechanisms underlying actions of certain long noncoding RNAs in Alzheimer's disease

Ahmadi S, Zobeiri M, Bradburn S.

Metab Brain Dis. 2020 Jun;35(5):681-693. doi: 10.1007/s11011-020-00564-9. Epub 2020 Mar 17.

The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer's Disease

Servizi S, Corrigan RR, Casadesus G.

Curr Pharm Des. 2020;26(12):1345-1355. doi: 10.2174/1381612826666200318151146.

Gut microbiota and pro/prebiotics in Alzheimer's disease

Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ.

Aging (Albany NY). 2020 Mar 19;12(6):5539-5550. doi: 10.18632/aging.102930. Epub 2020 Mar 19.

Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: Validation of icobrain dm

Struyfs H, Sima DM, Wittens M, Ribbens A, Pedrosa de Barros N, Phan TV, Ferraz Meyer MI, Claes L, Niemantsverdriet E, Engelborghs S, Van Hecke W, Smeets D.

Neuroimage Clin. 2020;26:102243. doi: 10.1016/j.nicl.2020.102243. Epub 2020 Mar 12.

Conformational change and GTPase activity of human tubulin: A comparative study on Alzheimer's disease and healthy brain

Rajaei S, Karima S, Sepasi Tehrani H, Shateri S, Mahmoodi Baram S, Mahdavi M, Mokhtari F, Alimohammadi A, Tafakhori A, Amiri A, Aghamollaii V, Fatemi H, Rajabibazl M, Kobarfard F, Gorji A.

J Neurochem. 2020 Sep;155(2):207-224. doi: 10.1111/jnc.15009. Epub 2020 Apr 13.

Amyloid β-protein and beyond: the path forward in Alzheimer's disease

Walsh DM, Selkoe DJ.

Curr Opin Neurobiol. 2020 Apr;61:116-124. doi: 10.1016/j.conb.2020.02.003.

Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer's Disease

Gião T, Saavedra J, Cotrina E, Quintana J, Llop J, Arsequell G, Cardoso I.

Int J Mol Sci. 2020 Mar 18;21(6):2075. doi: 10.3390/ijms21062075.

The Na(+)/Ca(2+)exchanger in Alzheimer's disease

Pannaccione A, Piccialli I, Secondo A, Ciccone R, Molinaro P, Boscia F, Annunziato L.

Cell Calcium. 2020 May;87:102190. doi: 10.1016/j.ceca.2020.102190. Epub 2020 Mar 2.

Olesoxime improves cerebral mitochondrial dysfunction and enhances Aβ levels in preclinical models of Alzheimer's disease

Eckert GP, Eckert SH, Eckmann J, Hagl S, Muller WE, Friedland K.

Exp Neurol. 2020 Jul;329:113286. doi: 10.1016/j.expneurol.2020.113286. Epub 2020 Mar 18.

Emerging risk of environmental factors: insight mechanisms of Alzheimer's diseases

Rahman MA, Rahman MS, Uddin MJ, Mamum-Or-Rashid ANM, Pang MG, Rhim H.

Environ Sci Pollut Res Int. 2020 Dec;27(36):44659-44672. doi: 10.1007/s11356-020-08243-z. Epub 2020 Mar 23.

Alzheimer's Disease Research Enterprise in the Era of COVID-19/SARS-CoV-2

Alzheimers Dement. 2020 Apr;16(4):587-588. doi: 10.1002/alz.12093. Epub 2020 Mar 22.

Synchronous measuring of triptolide changes in rat brain and blood and its application to a comparative pharmacokinetic study in normal and Alzheimer's disease rats

Zhu S, Wang X, Zheng Z, Zhao XE, Bai Y, Liu H.

J Pharm Biomed Anal. 2020 Jun 5;185:113263. doi: 10.1016/j.jpba.2020.113263. Epub 2020 Mar 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias